Hydroxocobalamin
1 NDC across 1 manufacturer|1 Generic,0 Brand
Hydroxocobalamin is used to treat alcoholic neuropathy, pernicious anemia, diabetic neuropathies and multiple sclerosis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 15, 2006, and the first generic was approved Jan 1, 1982.
Hydroxocobalamin is available as 1 NDC from 1 manufacturer (1 generic, 0 brand), with NADAC prices from $0.81 to $0.81 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Active FDA drug shortage
2 Hydroxocobalamin presentations are currently listed in FDA's drug shortage database (first posted Nov 4, 2024). Shortages can move NADAC prices in the following weeks.
Total NDCs
1
1G / 0B
Manufacturers
1
competing in market
Price Spread
$0.81 – $0.81
per ML
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Actavis Pharma, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Antidote class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing HYDROXOCOBALAMIN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
HYDROXOCOBALAMIN 1,000 MCG/ML | $0.8144 per ML | — |
Frequently Asked Questions
What is Hydroxocobalamin used to treat?
Hydroxocobalamin is used to treat alcoholic neuropathy, pernicious anemia, diabetic neuropathies and multiple sclerosis, per the National Library of Medicine's MED-RT classification.
When did Hydroxocobalamin become available as a generic?
FDA approved the first generic Hydroxocobalamin (ANDA) on Jan 1, 1982.
Is Hydroxocobalamin in shortage?
Yes — FDA's drug shortage database currently lists 2 Hydroxocobalamin presentations with status "Current", first posted Nov 4, 2024.
How many Hydroxocobalamin products are on the market?
The Hydroxocobalamin drug market contains 1 NDC from 1 manufacturer — 1 generic and 0 brand products.
What is the price range for Hydroxocobalamin?
NADAC reference prices for Hydroxocobalamin range from $0.8144 to $0.8144 per ML.
Which manufacturers make Hydroxocobalamin?
1 manufacturer lists Hydroxocobalamin in NADAC. Ranked by number of NDCs, the largest are Actavis Pharma, Inc. (1).